PLoS ONE (Jan 2012)

Quantification of cytomegalovirus glycoprotein Bn DNA in hematopoietic stem cell transplant recipients by real-time PCR.

  • Xuan Zhang,
  • Ya Ping Huang,
  • Hai Nv Gao,
  • Mei Fang Yang,
  • Hong Zhao,
  • Jian Hua Hu,
  • Xiao Ming Chen,
  • Wei Hang Ma,
  • Jun Fan

DOI
https://doi.org/10.1371/journal.pone.0051224
Journal volume & issue
Vol. 7, no. 12
p. e51224

Abstract

Read online

Based on sequence variation in the N-terminus of the UL55 gene, which encodes glycoprotein B (gB), human cytomegalovirus (CMV) can be classified into four gBn genotypes. We assessed the distribution of CMV gBn genotypes and the correlation between CMV gBn DNA (detected by real-time PCR) and CMV-positive pp65 cells (identified by immunohistochemical staining) in a cohort of hematopoietic stem cell transplant patients. The distribution of gB genotypes was as follows: gBn1, 60% of patients; gBn2, 13.3%; mixed gBn1 and gBn3 infection, 26.7%; and gBn4 and other mixed infections, 0%. CMV gBn1 was the most common genotype. The detected level of CMV gB DNA correlated well with the number of CMV-positive pp65 cells detected by immunostaining (r = 0.585).